FDA approves Novo Nordisk’s 25mg oral semaglutide (Wegovy) for weight loss, aiding 16.6% body weight reduction vs. 2.7% placebo.  | Read More News from Israel  | Read More in Virtual Jerusalem.   Read More in Israel NOWlej.